Evidence map›Paper›PMID 35528243›Full record

ArticleJournal of oncology2022

Impact of Platelets to Lymphocytes Ratio and Lymphocytes during Radical Concurrent Radiotherapy and Chemotherapy on Patients with Nonmetastatic Esophageal Squamous Cell Carcinoma.

Yaotian Zhang, Ning Han, Xue Zeng, Chaonan Sun, Shichen Sun, Xinchi Ma, Yanyu Zhang, Zhuang Liu, Zilan Qin, Hong Guo and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yaotian ZhangDepartment of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Hospital and Institute, Shenyang Liaoning 110042, China.ORCID https://orcid.org/0000-0002-6421-3465
Ning HanDepartment of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Hospital and Institute, Shenyang Liaoning 110042, China.ORCID https://orcid.org/0000-0003-4362-7906
Xue ZengDepartment of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Hospital and Institute, Shenyang Liaoning 110042, China.
Chaonan SunDepartment of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Hospital and Institute, Shenyang Liaoning 110042, China.
Shichen SunDepartment of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Hospital and Institute, Shenyang Liaoning 110042, China.
Xinchi MaDepartment of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Hospital and Institute, Shenyang Liaoning 110042, China.
Yanyu ZhangDepartment of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Hospital and Institute, Shenyang Liaoning 110042, China.ORCID https://orcid.org/0000-0003-1047-494X
Zhuang LiuDepartment of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Hospital and Institute, Shenyang Liaoning 110042, China.
Zilan QinDepartment of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Hospital and Institute, Shenyang Liaoning 110042, China.
Hong GuoDepartment of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Hospital and Institute, Shenyang Liaoning 110042, China.
Yubing LiDepartment of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Hospital and Institute, Shenyang Liaoning 110042, China.ORCID https://orcid.org/0000-0003-3337-1230
Na ZhangDepartment of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Hospital and Institute, Shenyang Liaoning 110042, China.ORCID https://orcid.org/0000-0003-0403-0111
Liaoning Cancer Hospital & Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study examined the importance of hematological parameters as prognostic markers for people with esophageal cancer receiving radical concurrent chemoradiation. Methods: 106 patients with esophageal cancer are included in this study. Cox regression analysis, Kaplan-Meier method, and chi-square test were used to analyze our data. Results: The median follow-up time for patients was 15.5 months (3-55). Univariate and multivariate analyses showed that age, the change of platelet-to-lymphocyte ratio ( Conclusion:

Identifiers

PMID35528243
PMCPMC9076304
OpenAlexW4225161458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.